Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| We are going to continue to do that and we are proud of what we’ve accomplished |
| We more than doubled our overall revenue |
| On the service side, we are pleased that we were able to deliver 35% service gross margin in our first full quarter of providing our logistics service |
| Again, based on everything we know today, we are extremely confident and bullish on the potential positive impact of transplant logistics services on the growth of our NOP case volume and a more efficient utilization of our clinical resources |
| revenue also increased up over 100 -- 159% from the fourth quarter of 2022 and the U.S |
| So this achievement gives us confidence that we will be able to provide this service with a mid-30%s service gross margin or better as we grow our footprint in utilization of aviation |
| The NOP network infrastructure created by TransMedics has given us a unique ability to share our cost efficiencies with our transplant center users |
| So for the second consecutive year, we delivered on and even exceeded our aspirational -- our aspirations to double revenue year-over-year in the first years of OCS commercial launch |
| Overall, 2023 was a tremendous year for TransMedics, as we demonstrated the potential to grow our business while helping to increase the overall number of transplants |
| We are proud of this success in the first full quarter of operations |
| Based on everything we know today, we are growing extremely confident and bullish on the significant potential positive impact of TransMedics logistical services to help us grow the use of NOP platform |
| We continue to be extremely optimistic about our opportunities to continue to grow in 2024 and beyond |
| Very strong quarter |
| Based on everything we know today, we are extremely confident that we will be able to ramp the gross margin up over the next 12 months to 18 months, as we achieve more leverage of scale in our operations |
| In the meantime, we are thrilled that we achieved a 35% gross margin for our service business faster than we had projected, exceeding our early expectations |
| Also, for modeling purposes, we expect gross margins to improve throughout 2024 |
| We’re very humbled by and proud of TransMedics’ performance in 2023 |
| We are going to defend our practice, our success, our goal to grow transplant volumes, our ability to support these transplant institutions to deliver the best clinical support for their organs and for their patients as we have been doing for the past 25 years |
| We are grateful for your world-class effort, commitment and creativity in navigating every operational challenge of our rapidly growing business in 2023 |
| Importantly, I want to make it crystal clear that we are now gearing up for another strong year of execution in 2024 |
| The bottomline for us is, we know and we are confident that we are providing an operationally scalable and the most efficient cost structure in transplant logistics in the United States and it’s going to get better from here as we have more leverage and more plane and more capacity to meet many of these cases |
| In totality, we set a solid foundation for sustained growth of our business and our mission of growing transplant volumes to help patients in need for an organ transplant |
| We are confident that this sustained growth and success of NOP is based solely on the operational efficiency to grow transplant volumes, highest level of clinical care of donor organs and the overall cost efficiency experienced by transplant programs across the United States |
| Congrats on a strong finish to a remarkable year |
| We ended the year on a very strong note, laying a solid foundation for continued growth |
| This will be fueled further by our unique ability to also expand the overall national growth of transplant volumes in the U |
| Based on our OCS case number and donor mix, we are confident that our OCS technology and NOP services were primary drivers for this annual transplant volume growth |
| We will get the number of procedure up, we will see the long-term effect of OCS as we will start reporting that at the next ISHLT and we are extremely confident that the heart will pick up the pace |
| heart and liver transplant volumes by double-digit numbers |
| We’re focusing on driving more organ transplants in this country successfully with excellent results using our NOP service and now our logistics service |
| Statement |
|---|
| Five, lack of control over air safety standards of these contracted chartered, sorry, of these contracted local or regional operators flying 20-year, 30-year-old aircrafts |
| Two, significant shortage of charter plane availability for 24x7 to cover the growing demand for transplant mission |
| Four, lack of control over the starting location of the aircraft led to use of highly inefficient routes, which added even more costs in order to reposition the aircraft |
| Unfortunately, we quickly learned through firsthand experience that the brokered charter flight model had significant limitations to help grow the transplant volume in the U.S |
| We did experience an unfavorable impact to product margin of about 300 basis points that will not repeat in Q1, which was related to the end-of-year inventory cleanup and adjustments |
| Our overall gross margin for 4Q was 59%, down from 66% in 4Q 2022 |
| Three, the lack of control over the planes and pilots by most charter brokers, often resulting in the use of more than one plane and multiple crews to complete a single mission, which sometimes doubled the transportation bill paid by the transplant center |
| It was completely unfounded |
| This resulted in the loss of approximately 20% to 30% of donor retrieval missions for NOP in 2022 and early 2023 |
| national organ allocation loss and the use of OCS technology and it’s -- an NOP |
| This is an important metrics to unequivocally show that operational availability, cost efficiency and high safety standards enabled us to disrupt the inefficient historical model and take market share relatively quickly |
| Importantly, it is also severely -- it also severely limits the ability to grow transplant volumes due to the shortage of dedicated aircrafts and we saw it as a roadblock to our stated goal and commitment to growing the U.S |
| So while this asset model might be light for the broker, it is clearly a very heavy financial burden to the transplant centers and payers who ended up paying multiple middlemen |
| This regional charter brokerage approach was very operationally inefficient and added significant costs to the transplant centers due to; one, fragmented local and regional operators using older aircrafts that were not capable of covering the new longer range donor missions now afforded by the new U.S |
| It is clear that what TransMedics is doing in the area of transplant logistics is disrupting this antiquated charter brokerage model for organ transplantation |
| One is we -- part of the service revenue this quarter was some overhang from non-transplant-related revenue |
| So, again, it’s unfortunate what’s going on, but as you said, it’s been going on for several years |
| This is down from 66% in the fourth quarter of 2022 and reflects the higher NOP service component of our business, which was still in the early stage in Q4 of 2022 |
| All these added significant and unnecessary cost burden to the transplant centers |
| These compare with an operating loss of $6.8 million in Q4 of 2022 and a net loss of $6.7 million in Q4 of 2022 |
Please consider a small donation if you think this website provides you with relevant information